Belgian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

1 new

Companies which are more than 50% undervalued based on analyst price target.

2 companies

Financière de Tubize

Market Cap: €8.3b

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.

TUB

€186.80

-4.8%

21.1%

Hyloris Pharmaceuticals

Market Cap: €131.6m

Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.

HYL

€4.70

-26.8%